China greenlights three sci-tech innovation IPOs
BEIJING, Aug. 7 (Xinhua) -- China's securities regulator has approved the initial public offerings (IPOs) of three companies on the science and technology innovation board.
Hi-Trend Technology (Shanghai) Co., Ltd., Jadard Technology Inc., and InnoCare Pharma Limited will be listed on the Shanghai Stock Exchange's sci-tech innovation board, commonly known as the STAR market, according to the China Securities Regulatory Commission.
The companies and their underwriters will confirm the dates of the IPO and publish prospectuses following discussions with the stock exchange.
The STAR market, inaugurated in June 2019 and designed to support companies in the high-tech and strategic emerging sectors, has eased its listing criteria but adopted higher requirements for information disclosure.
Photos
Related Stories
- Beijing bourse sees 100 IPOs in seven months
- China greenlights two sci-tech innovation IPOs
- China greenlights sci-tech innovation IPO
- China greenlights IPO registration on Nasdaq-style board
- China approves IPO application of CNOOC Limited
- China greenlights three sci-tech innovation IPOs
- American capital market remains discriminative toward Chinese IPOs
- China ups security review for online platforms seeking overseas IPOs
- China greenlights two ChiNext IPOs
- Chinese A-share IPOs, funds raised hit record high on registration-based system
Copyright © 2022 People's Daily Online. All Rights Reserved.